Needle and syringe programs in Yunnan, China yield health and financial return
<p>Abstract</p> <p>Background</p> <p>As a harm reduction strategy in response to HIV epidemics needle and syringes programs (NSPs) were initiated throughout China in 2002. The effectiveness of NSPs in reducing the spread of infection in such an established epidemic is u...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-04-01
|
| Series: | BMC Public Health |
| Subjects: | |
| Online Access: | http://www.biomedcentral.com/1471-2458/11/250 |
| _version_ | 1818021095043760128 |
|---|---|
| author | Xun Zhuang Wu Zunyou Yap Lorraine Zhang Lei Wilson David P |
| author_facet | Xun Zhuang Wu Zunyou Yap Lorraine Zhang Lei Wilson David P |
| author_sort | Xun Zhuang |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>As a harm reduction strategy in response to HIV epidemics needle and syringes programs (NSPs) were initiated throughout China in 2002. The effectiveness of NSPs in reducing the spread of infection in such an established epidemic is unknown. In this study we use data from Yunnan province, the province most affected by HIV in China, to (1) estimate the population benefits in terms of infections prevented due to the programs; (2) calculate the cost-effectiveness of NSPs.</p> <p>Methods</p> <p>We developed a mathematical transmission model, informed by detailed behavioral and program data, which accurately reflected the unique HIV epidemiology among Yunnan injecting drug users (IDUs) in the presence of NSPs. We then used the model to estimate the likely epidemiological and clinical outcomes without NSPs and conducted a health economics analysis to determine the cost-effectiveness of the program.</p> <p>Results</p> <p>It is estimated that NSPs in Yunnan have averted approximately 16-20% (5,200-7,500 infections) of the expected HIV cases since 2002 and led to gains of 1,300-1,900 DALYs. The total $1.04 million spending on NSPs from 2002 to 2008 has resulted in an estimated cost-saving over this period of $1.38-$1.97 million due to the prevention of HIV and the associated costs of care and management.</p> <p>Conclusion</p> <p>NSPs are not only cost-effective but cost-saving in Yunnan. Significant scale-up of NSPs interventions across China and removal of the societal and political barriers that compromise the effects of NSPs should be a health priority of the Chinese government.</p> |
| first_indexed | 2024-04-14T08:14:14Z |
| format | Article |
| id | doaj.art-0e098f9a15d4437d937210412336eb0c |
| institution | Directory Open Access Journal |
| issn | 1471-2458 |
| language | English |
| last_indexed | 2024-04-14T08:14:14Z |
| publishDate | 2011-04-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Public Health |
| spelling | doaj.art-0e098f9a15d4437d937210412336eb0c2022-12-22T02:04:27ZengBMCBMC Public Health1471-24582011-04-0111125010.1186/1471-2458-11-250Needle and syringe programs in Yunnan, China yield health and financial returnXun ZhuangWu ZunyouYap LorraineZhang LeiWilson David P<p>Abstract</p> <p>Background</p> <p>As a harm reduction strategy in response to HIV epidemics needle and syringes programs (NSPs) were initiated throughout China in 2002. The effectiveness of NSPs in reducing the spread of infection in such an established epidemic is unknown. In this study we use data from Yunnan province, the province most affected by HIV in China, to (1) estimate the population benefits in terms of infections prevented due to the programs; (2) calculate the cost-effectiveness of NSPs.</p> <p>Methods</p> <p>We developed a mathematical transmission model, informed by detailed behavioral and program data, which accurately reflected the unique HIV epidemiology among Yunnan injecting drug users (IDUs) in the presence of NSPs. We then used the model to estimate the likely epidemiological and clinical outcomes without NSPs and conducted a health economics analysis to determine the cost-effectiveness of the program.</p> <p>Results</p> <p>It is estimated that NSPs in Yunnan have averted approximately 16-20% (5,200-7,500 infections) of the expected HIV cases since 2002 and led to gains of 1,300-1,900 DALYs. The total $1.04 million spending on NSPs from 2002 to 2008 has resulted in an estimated cost-saving over this period of $1.38-$1.97 million due to the prevention of HIV and the associated costs of care and management.</p> <p>Conclusion</p> <p>NSPs are not only cost-effective but cost-saving in Yunnan. Significant scale-up of NSPs interventions across China and removal of the societal and political barriers that compromise the effects of NSPs should be a health priority of the Chinese government.</p>http://www.biomedcentral.com/1471-2458/11/250HIVinjecting drug usersYunnanChinaneedle-syringe programsmathematical modelhealth economics |
| spellingShingle | Xun Zhuang Wu Zunyou Yap Lorraine Zhang Lei Wilson David P Needle and syringe programs in Yunnan, China yield health and financial return BMC Public Health HIV injecting drug users Yunnan China needle-syringe programs mathematical model health economics |
| title | Needle and syringe programs in Yunnan, China yield health and financial return |
| title_full | Needle and syringe programs in Yunnan, China yield health and financial return |
| title_fullStr | Needle and syringe programs in Yunnan, China yield health and financial return |
| title_full_unstemmed | Needle and syringe programs in Yunnan, China yield health and financial return |
| title_short | Needle and syringe programs in Yunnan, China yield health and financial return |
| title_sort | needle and syringe programs in yunnan china yield health and financial return |
| topic | HIV injecting drug users Yunnan China needle-syringe programs mathematical model health economics |
| url | http://www.biomedcentral.com/1471-2458/11/250 |
| work_keys_str_mv | AT xunzhuang needleandsyringeprogramsinyunnanchinayieldhealthandfinancialreturn AT wuzunyou needleandsyringeprogramsinyunnanchinayieldhealthandfinancialreturn AT yaplorraine needleandsyringeprogramsinyunnanchinayieldhealthandfinancialreturn AT zhanglei needleandsyringeprogramsinyunnanchinayieldhealthandfinancialreturn AT wilsondavidp needleandsyringeprogramsinyunnanchinayieldhealthandfinancialreturn |